Gastrointestinal tolerance of erythritol and xylitol
ingested in a liquid
D Storey1, A Lee1, F Bornet2 and F Brouns3
Biomedical Science Research Institute, School of environment and Life Sciences, The University of Salford, Salford, Greater Manchester,UK; 2Nutrihealth Consulting & Clinical research, F-92599 Rueil-Malmaison, F, Vilvoorde, Belgium and 3TDC food, Cerestar Vilvoorde Research and Development Centre, Vilvoorde, Belgium
Objectives: To determine and compare the gastrointestinal (GI) responses of young adults following consumption of 45 g
sucrose, 20, 35 and 50 g xylitol or erythritol given as a single oral, bolus dose in a liquid.
Design: The study was a randomized, double-blind, placebo-controlled study.
Subjects: Seventy healthy adult volunteers aged 18–24 years were recruited from the student population of the University of
Salford. Sixty-four subjects completed the study.
Interventions: Subjects consumed at home without supervision and in random order, either 45 g sucrose or 20, 35 and 50 g
erythritol or xylitol in water on individual test days, while maintaining their normal diet. Test days were separated by 7-day
washout periods. Subjects reported the prevalence and magnitude of flatulence, borborygmi, bloating, colic, bowel movements
and the passage of faeces of an abnormally watery consistency.
Results: Compared with 45 g sucrose, consumption of a single oral, bolus dose of 50 g xylitol in water significantly increased the
number of subjects reporting nausea (P<0.01), bloating (P<0.05), borborygmi (P<0.005), colic (P<0.05), watery faeces
(P<0.05) and total bowel movement frequency (P<0.01). Also 35 g of xylitol increased significantly bowel movement
frequency to pass watery faeces (P<0.05). In contrast, 50 g erythritol only significantly increased the number of subjects
reporting nausea (P<0.01) and borborygmi (P<0.05). Lower doses of 20 and 35 g erythritol did not provoke a significant
increase in GI symptoms. At all levels of intake, xylitol produced significantly more watery faeces than erythritol: resp. 50 g xylitol
vs 35 g erythritol (P<0.001), 50 g xylitol vs 20 g erythritol (P<0.001) and 35 g xylitol vs 20 g erythritol (P<0.05).
Conclusions: When consumed in water, 35 and 50 g xylitol was associated with significant intestinal symptom scores and
watery faeces, compared to the sucrose control, whereas at all levels studied erythritol scored significantly less symptoms.
Consumption of 20 and 35 g erythritol by healthy volunteers, in a liquid, is tolerated well, without any symptoms. At the highest
level of erythritol intake (50 g), only a significant increase in borborygmi and nausea was observed, whereas xylitol intake at this
level induced a significant increase in watery faeces.
Sponsorship: Cerestar R&D Center, Vilvoorde, Belgium.
European Journal of Clinical Nutrition advance online publication, 20 September 2006; doi:10.1038/sj.ejcn.1602532
INTRODUCTION
Polyols are widely used to replace sugars in foods, especially
confectionery, because of their low energy content, noncariogenicity
and their potential to help reduce glycaemic
and insulinaemic responses, when substituted for
sugars. However, when ingested in excessive quantities,
most polyols may cause undesirable, sometimes
stressful gastrointestinal (GI) symptoms (Zumbe et al.,
2001). Although transient, such symptoms may invite
unnecessary medical visits, especially in children.
Erythritol is a naturally occurring four-carbon polyol. It is
industrially produced using a fermentation process. Having a
sweetness approaching 60–80% that of sucrose, it has
sensorial and functional properties that allow the formulation
of low-calorie and diet beverages (as well as other
applications such as chewing gum, mints and chocolate
(Goosens and Ro¨per, 1994; de Cock, 1999; de Cock and Bechert, 2002)).
Erythritol is rapidly absorbed in the upper intestine
by a concentration-dependent diffusion process (Schiweck
and Ziesenitz, 1996) and has no effect on plasma glucose
and insulin (Ishikawa et al., 1996; Bornet et al., 1996a, b).
Erythritol is only minimally fermented in the oral cavity
by Streptococcus mutans (Kanwanabe et al., 1992) and
not fermented in the colon (Arrigoni et al., 2005). As a
result, erythritol has an estimated energy value of 0 kcal/g
(de Cock and Bechert, 2002; Arrigoni et al., 2005), compared
to 4 kcal/g for sucrose (Paul and Southgate, 1978). After oral
intake, most erythritol is excreted with urine, excretion
being 60–78% of an oral dose after 24 h (Bornet et al.,
1996a, b) and 90% after 48 h (Munro et al., 1998) have
been observed. Thus, in contrast to other monosaccharide
and disaccharide polyols, only small amounts of ingested
erythritol remain unabsorbed in the intestinal tract.
Acute doses of up to 25 g erythritol are reported not to lead
to excess intestinal fermentation (Hiele et al., 1993).
Nausea, borborygmi, bloating, flatulence and soft faeces
following consumption of 0.4 and 0.8 g/kg body weight
(BW) erythritol by healthy subjects were observed by
Bornet et al. (1996b). However, these GI responses were not
significantly different from those following ingestion
of equivalent doses of sucrose. Tetzloff et al. (1996)
observed that a daily dose of 1 g/kg BW erythritol (mean
intake 78 g/day), ingested in small portions throughout
the day, during 5 consecutive days, was well tolerated and
did not cause untoward GI disturbances compared with
an equivalent dose of sucrose. Based on regression analysis,
Oku and Okazaki (1996) concluded that the maximum
dose of erythritol not causing laxation is 0.80 g/kg BW for
females and 0.66 g/kg BW for males. This figure should be
seen as an approximation, as linear regression may
overestimate the cutoff point due to the binomial nature of
the data.
Xylitol is a naturally occurring monosaccharide – pentitol
polyol – with a wide range of applications in sugar-free
confectionery (Pepper and Ollinger, 1988). Because of its
non-cariogenic properties (Maguire et al., 2000), xylitol is
often the polyol of choice in sugar-free chewing gum (Zumbe
et al., 2001). Diarrhoea, flatulence and bloating have been
reported by Dubach et al. (1969) in adults following
consumption of xylitol, although no dose dependency was
noted. In another study by Culbert et al. (1986) in which
participants consumed 30–100 g xylitol per day, a dosedependent
effect was observed. Although erythritol and
xylitol have similar physicochemical properties and are
being used in a wide variety of food applications, little is
known about their comparative GI tolerance, especially
when consumed at higher doses in liquid. The latter has
received recent interest related to the advice of some expert
groups to reduce overall daily glycaemic responses by
substituting rapidly available carbohydrates for low glycaemic
sweeteners. This paper investigates the GI tolerance of
young adults (18–24 years) given 400 ml drinks, containing
either 45 g sucrose or 20, 35 and 50 g of erythritol or xylitol.
METHODS
Subjects
Seventy healthy, non-adapted volunteers, 34 males and 36
females, aged between 18 and 24 years, were randomly
recruited from the student population of the University of
Salford. The purpose and nature of the proposed studies were
explained to volunteers who provided written consent and
were free to leave the study at any time and for any reason.
Studies were approved by the Salford Health Authority
Regional Ethics Committee. Potential recruits were included
according to the procedures as described by Lee and Storey
(1999). Body mass indices (mean7s.d.) were 24.5474.46
and 22.3472.60 kg/m2 for males and females, respectively.
Five male subjects failed to complete the study. Of these,
three dropped out because of illnesses unrelated to the study
and two because of adverse GI effects following consumption
of xylitol containing test products. All female subjects
completed the study satisfactorily. Subjects received remuneration
for travel expenses and the inconvenience of
participating in studies.
Test materials
Test materials were provided as 400 ml orange-flavoured
non-carbonated drinks (2x200 ml glass bottles), containing
either sucrose, erythritol or xylitol (Table 1). All drinks were
supplied by Cerestar R&D, Vilvoorde, Belgium. Differences in
sweetness intensity were corrected to 11.25 sucrose equivalent
value for all test drinks with the use of aspartame. Test
drinks were identified by one of seven different code
numbers, the identities of which were not revealed to the
investigators or subjects until completion of the study.
Study design and restrictions
The study was a randomized, double-blind, placebocontrolled
study. Subjects consumed test drinks separated
by 7-day washout periods, while maintaining their customary,
normal diet. Product allocation was randomized according
to a Latin square design. Dietary restrictions (e.g. no prior
consumption of polyol-containing products) were enforced
according to Lee and Storey (1999). Subjects consumed test
drinks according to choice, either as a mid-morning or mid-afternoon drink, after having consumed a normal breakfast
or lunch. Drinks were consumed within 15 min. Subjects
were requested not to consume any food or drinks in the 2-h
period following consumption of test drinks, except for up to
300 ml water to quench thirst. Each subject was individually
debriefed 24 h after consumption of each test drink to
determine adherence to dietary restrictions and consumption
regimen, and to assess GI responses.
| Table 1- Composition of test drinks (g per 400 ml) |
|
| Test Drink |
Sucrose |
Erythritol |
Xylitol |
| 1 |
45 |
- |
- |
| 2 |
- |
20 |
- |
| 3 |
- |
35 |
- |
| 4 |
- |
50 |
- |
| 5 |
- |
- |
20 |
| 6 |
- |
- |
35 |
| 7 |
- |
- |
50 |
|
GI symptoms
Subjects were given printed sheets on which to record the
incidence and magnitude of GI responses and details of their
bowel movements for the 24-h period following consumption
of test products. Notifiable responses were nausea,
borborygmi, colic, bloating and flatulence. Each response
was ranked on a hedonic scale, where 0 indicated ‘normal’
function, 1 indicated ‘slightly more symptom than usual’, 2
indicated ‘noticeably more symptom than usual’ and 3
indicated ‘considerably more symptom than usual’. Subjects
recorded the number of bowel movements to pass faeces of
normal, hard or watery consistency, where watery faeces
were defined as those of an abnormally watery consistency
(loss of firm shape owing to high water content). Information
regarding faecal volume was not collected.
Statistics
Symptom responses were classified as categorical, and
considered to be non-parametric. GI responses following
consumption of different test drinks were compared by 2x2
contingency table analysis (w2) according to the methods of
McNemar (1947). The binomial test was used when the
expected frequency in each cell of the contingency table was
less than 5. w2 was used to test for differences in the
occurrence of multiple symptoms following consumption of
products. Symptom scores following consumption of test
drinks were derived by summing each subject’s GI responses,
where 0¼normal, 1¼‘slightly more symptom than usual’,
2¼‘noticeably more symptom than usual’ and 3¼‘considerably
more symptom than usual’. The frequency of bowel
movements to pass normal, watery and hard faeces were
analysed by one-way analysis of variance, followed by
Dunnet’s post hoc test to locate differences in case of an
overall significant treatment effect.
Results
Sixty-five subjects completed the study. In one subject, part
of the GI symptoms reporting was incomplete. Accordingly,
analysis was carried out on 64 subjects where appropriate.
Table 2 shows the number of subjects experiencing GI
symptoms following consumption of drinks containing 45 g
sucrose and 20, 35 and 50 g erythritol or xylitol. Compared
with 45 g sucrose, consumption of 20 g xylitol was associated with a significant increase in the number of subjects
reporting nausea (P<0.01) and consumption of 35 g xylitol
resulted in a significant increase of the number of subjects
reporting watery faeces. Intake of 50 g xylitol was associated
with a significant increase in the number of subjects
reporting nausea (P<0.01), bloating (P<0.05), borborygmi
(P<0.01), colic (P<0.05) and watery faeces (P<0.005). In
contrast, consumption of 50 g erythritol was associated with
only a significant increase in the number of subjects
reporting nausea (P<0.01) and borborygmi (P<0.05).
Table 3 shows the frequency of all bowel movements to
pass normal, watery and hard faeces in the 24 h following
consumption of test drinks. Compared with 45 g sucrose,
consumption of 50 g xylitol significantly increased total
bowel movement frequency (P<0.01). At all levels of intake,
xylitol produced more watery faeces than erythritol: resp.
50 g xylitol vs 35 g erythritol (P<0.001), 35 g xylitol vs 20 g
erythritol (P<0.05) and 50 g xylitol vs 20 g erythritol
(P<0.001).
Symptom scores were dose dependent following consumption
of increasing doses of xylitol and erythritol (Figure 1).
Consumption of 50 g erythritol and xylitol was associated
with a significant increase in the mean symptom score
(P<0.001 in both cases), compared with 45 g sucrose.
Consumption of 35 g xylitol was also associated with a
significant increase in the mean symptom score compared
with 45 g sucrose (P<0.005). However, 20 and 35 g erythritol
and 20 g xylitol did not significantly increase mean symptom
scores. There was a significant difference in mean
symptom scores following consumption of 20, 35 and 50 g
xylitol compared with equivalent doses of erythritol
(P<0.025, o0.05 and o0.005, respectively).
Few subjects experienced more than three symptoms
following consumption of any test drinks. However, consumption
of 50 g xylitol was associated with a significant
increase in the number of subjects experiencing three or
more GI symptoms compared with 45 g sucrose (P<0.001).
Discussion
GI symptoms following consumption of polyols, including
abdominal pain and increased laxation, are well documented,
but less so for xylitol and erythritol (Livesey, 2001;
Zumbe et al., 2001). Some factors affecting tolerance include
the dose of polyol ingested, type of polyol (be it monosaccharide,
disaccharide or polysaccharide), the medium of
ingestion, consumption pattern, the individual GI tolerance
of the individual and composition of the colonic flora
(Cummings et al., 2001; Marteau and Flourie, 2001).
| Table 2 - GI symptoms in the 24 h following consumption of test drinks containing 45 g sucrose and 20, 35 and 50 g erythritol or xylitol (number of subjects reporting symptoms, n=65(a)) |
|
| Symptom(b) |
45 g Sucrose |
20 g Erythritol |
20 g Xylitol |
35 g Erythritol |
35 g Xylitol |
50 g Erythritol |
50 g Xylitol |
| Nausea (n=64) |
| 0 |
58 |
54 |
47 |
50 |
49 |
44 |
43 |
| 1 |
3 |
8 |
14** |
8 |
11 |
10 |
4 |
| 2 |
3 |
2 |
2 |
5 |
4 |
6 |
15 |
| 3 |
0 |
0 |
1 |
1 |
0 |
4 |
2 |
| Total |
6 |
10 |
17* |
14 |
15 |
20* |
21** |
| Bloating (n=64) |
| 0 |
53 |
55 |
53 |
50 |
45 |
45 |
41 |
| 1 |
8 |
9 |
7 |
11 |
16 |
13 |
14 |
| 2 |
3 |
0 |
3 |
3 |
3 |
5 |
8 |
| 3 |
0 |
0 |
1 |
0 |
0 |
1 |
1 |
| Total |
11 |
9 |
11 |
14 |
19 |
19 |
23* |
| Borborygmi (n=64) |
| 0 |
49 |
48 |
42 |
51 |
42 |
40 |
31 |
| 1 |
13 |
14 |
16 |
9 |
14 |
12 |
22 |
| 2 |
2 |
2 |
4 |
1 |
5 |
8 |
8 |
| 3 |
0 |
0 |
2 |
3 |
3 |
4 |
3 |
| Total |
15 |
16 |
22 |
13 |
22 |
24* |
33** |
| Colic (n=64) |
| 0 |
56 |
58 |
54 |
50 |
53 |
48 |
44 |
| 1 |
5 |
5 |
5 |
9 |
7 |
9 |
11 |
| 2 |
3 |
1 |
4 |
4 |
3 |
7 |
8 |
| 3 |
0 |
0 |
1 |
1 |
1 |
0 |
1 |
| Total |
8 |
6 |
10 |
14 |
11 |
16 |
20* |
| Flatulence (n=64) |
| 0 |
46 |
52 |
47 |
50 |
45 |
44 |
40 |
| 1 |
14 |
10 |
12 |
12 |
15 |
15 |
16 |
| 2 |
4 |
2 |
5 |
2 |
4 |
5 |
7 |
| 3 |
0 |
0 |
0 |
1 |
0 |
0 |
1 |
| Total |
18 |
12 |
17 |
14 |
19 |
20 |
24 |
| Watery faeces (n=65) |
| none |
56 |
60 |
51 |
54 |
43 |
46 |
37 |
| 1(c) |
7 |
5 |
10 |
7 |
10 |
9 |
10 |
| 2 |
1 |
0 |
4 |
3 |
6 |
5 |
8 |
| 3+ |
1 |
0 |
0 |
1 |
6 |
5 |
10 |
| Total |
9 |
5 |
14 |
11 |
22* |
19 |
28** |
|
Abbreviation: GI, gastrointestinal.
(a) Sixty-five subjects completed the study. In one subject, part of the GI symptoms reporting was incomplete. Accordingly, analysis was carried out on 64 subjects
where appropriate.
(b) 0¼Normal (no more symptom than usual), 1¼slightly more symptom than usual, 2¼Noticeably more symptom than usual and 3¼considerably more symptom
than usual.
(c) Number of bowel movements to pass watery faeces. Symptom responses were classified as categorical, and considered to be non-arametric. GI responses following
consumption of test drinks were compared by 2x2 contingency table analysis (w2) according to the methods of McNemar (1947). The binomial test was used when
the expected frequency in each cell of the contingency table was less than 5. w2 was used to test for differences in the occurrence of multiple symptoms following
consumption of products.
*Significant increase in number of subjects experiencing symptom compared to 45 g sucrose, *Po<0.05, **Po<0.01. |
Disaccharide polyols such as isomalt are generally better
tolerated than monosaccharide polyols such as sorbitol,
which exerts a greater osmotic load in the GI tract (Zumbe
and Brinkworth, 1992; Lee et al., 1994). The dose of sorbitol
and xylitol in confectionery is usually less than 20 g,
presumably to limit adverse GI effects (Zumbe et al., 2001).
Although both xylitol and erythritol have a high osmotic
potential in the GI tract, consumption of xylitol in this study
was associated with significantly more subjects experiencing
GI symptoms, increased laxation and elevated symptom
scores compared with equivalent doses of erythritol.
Molecular size is important with respect to the extent of
polyol absorption in the small intestine (Livesey, 1992).
Sorbitol has a molecular weight of 182, which is close to the
limit for passive diffusion in the upper intestine (Dwivedi,
1978), xylitol a molecular weight of 152 and erythritol 122
(Zumbe et al., 2001). Thus, the low molecular weight of
erythritol may explain its rapid absorption in the upper
intestine leaving little unabsorbed to provoke osmotically
induced GI symptoms.
Human studies have shown that 60–90% of ingested
erythritol is rapidly absorbed across the small intestine, the
majority excreted unmetabolized in the urine and only small
amounts excreted in faeces (Hiele et al., 1993; Bornet et al.,1992, 1996a, b; Noda et al., 1994). However, estimates for
upper intestinal absorption and urinary excretion of erythritol
in these studies are dependent on the urinary
collection period. Munro et al. (1998) consider that between
24 and 48 h at least 90% of ingested erythritol is excreted,
leaving 10% for potential microbial fermentation in the large
bowel. Thus, 24-h urine sampling may underestimate
absorption because the remainder is excreted between 24
and 48 h. In comparison, little information is available
regarding the extent of small intestinal absorption of xylitol,
although Asano et al. (1973) estimate that only 50% of a 30 g
daily dose is absorbed in the upper intestine.
| Table 3 - Frequency of bowel movements to pass normal, watery and hard faeces in the 24 h following consumption of test drinks containing 45 gsucrose, 20, 35 and 50 g erythritol or xylitol/mean (s.d.) (n=65) |
|
| |
45 g Sucrose |
20 g Erythritol |
20 g Xylitol |
35 g Erythritol |
35 g Xylitol |
50 g Erythritol |
50 g Xylitol |
| Normal faeces |
1.06±0.87 |
1.03±0.84 |
0.92±0.83 |
1.05±0.88 |
0.89±0.81 |
0.89±0.81 |
0.75±0.70 |
| Watery faeces |
0.20±0.61 |
0.08±0.27 |
0.28±0.57 |
0.28±0.77 |
066±1.13* |
0.62±1.22 |
1.09±1.7** |
| Hard faeces |
0.03±0.17 |
0.03±0.17 |
0.11±0.47 |
0.06±0.24 |
0.05±0.21 |
0.06±0.30 |
0.15±0.40 |
| Total bowel movements |
1.29±0.99 |
1.14±0.94 |
1.31±0.96 |
1.38±1.16 |
1.60±1.13 |
1.57±1.26 |
2.00±1.62** |
|
*Significant increase (analysis of variance) in bowel movement frequency compared to 45 g sucrose, **P<0.01.
Other observed differences (Dunnet’s post hoc test) 20 g erythritol vs 50 g erythritol (P<0.05), 20 g erythritol vs 35 g xylitol (P<0.05), 20 g erythritol vs 50 g xylitol
(P<0.001), 35 g erythritol vs 50 g xylitol (P<0.001) and 20 g xylitol vs 50 g xylitol (P<0.001). |
In this study, consumption of 35 g xylitol resulted in
watery faces and 50 g xylitol was associated with a significant
increase in all symptoms, except flatulence. In contrast,
intake of 50 g erythritol provoked only mild nausea and
borborygmi. These results suggest that a higher fraction of
ingested xylitol passes into the large bowel provoking more
symptoms owing to osmotic and fermentation related
effects. Table 3 shows the pronounced osmotic effect of
50 g xylitol, with bowel movement frequencies to pass
watery faeces of 1.0971.70 and faeces of normal consistency
of 0.7570.70 (mean7s.d.). This suggests that during xylitol
consumption, watery faeces were passed at the expense of
faeces of a normal consistency.
Figure 1 - Number of bowel movements by the total study group
(n=65) to pass watery faeces in the 24 h following consumption of a
bolus dose of 400 ml orange flavoured drinks containing 45 g
sucrose or 20, 35 and 50 g erythritol or xylitol. *Significant increase
in the number of bowel movements to pass watery faeces compared
to 45 g sucrose, *P<0.05, **P<0.01. |
|
 |
Nausea is not uncommon following polyol consumption.
Ingestion of erythritol, sorbitol, lactulose, maltitol and Dtagatose
have reportedly caused nausea in some subjects,
presumably due to high fluid influx into the upper intestinal
lumen (Lanthier and Morgan, 1985; Lederle et al., 1990;
Beaugerie et al., 1991; Oku and Okazaki, 1996; Bornet et al.,
1996a; Lee and Storey, 1999).
Figure 1 clearly shows that laxation scores were dose
dependent following consumption of single doses of erythritol
and xylitol. However, Tetzloff observed that when
1 g/kg BW was ingested in portions spread over the day, no
GI disturbances were observed with erythritol, compared
with an equivalent amount of sucrose (Tetzloff et al., 1996).
These results are broadly in keeping with results of this study,
confirming that 20 and 35 g erythritol provoke no significant
GI responses and up to (or at least) 50 g erythritol is
associated with only mild nausea and borborygmi and
laxation. However, it is important to emphasize that
occurrence of GI symptoms following consumption of
polyols is influenced by the time over which they are
consumed. Ingesting small amounts over time has been
shown to result in less symptoms than consuming the same
amount as one single bolus (Storey et al., 2002).
Although this study was not designed to derive a precise
laxative threshold for erythritol (the maximum dose at
which no individual responds with laxation), in terms of
g/kg BW intake, an approximate figure for comparison with
other studies that did define such a threshold may be
derived. Consumption of 50 g erythritol did not significantly
increase the number of subjects passing watery faeces. This
dose equates to 0.7870.19 g/kg BW (mean7s.d.), based
upon the body mass of subjects in this study, which is close
to the laxative threshold level as determined by Bornet et al.
(1996b) and Oku and Okazaki (1996). Compared to placebo,
35 g xylitol provoked a significant increase in the number of
subjects passing watery faeces and at all levels of intake
xylitol induced more GI distress than erythritol. Interestingly,
recent results of 24 h in vitro fermentation studies,
using human faecal inoculum and measuring substrate
disappearance as well as fermentation products, have shown
that erythritol is not fermented (Arrigoni et al., 2005).
Accordingly, at moderate doses erythritol is not expected
to have a substantial impact on GI symptoms such as
abdominal colic and flatulence.
Overall the data of this study show that when consumed as
a liquid in a drink, erythritol is not associated with the occurrence of multiple symptoms, whereas consumption
of 50 g xylitol provoked a significant increase in the
occurrence of both osmotic and fermentative intolerance
symptoms. We conclude that consumption of up to 35 g
erythritol by healthy volunteers, in water, is tolerated well,
without any symptoms. The highest level of intake, 50 g,
provoked only significant increases in borborygmi and
nausea.
Acknowledgements
We acknowledge Dr P Scarf (Director, Centre for Operational
Research and Applied Statistics at the University of Salford)
for initial advice on statistical methodology.
|